Susquehanna International Group, LLP Alaunos Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.04 - $0.13 $678 - $2,206	16,970 Added 13.83%	139,634 $9,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.5 $43,955 - $183,148	-366,297 Reduced 74.91%	122,664 $15,000
Q2 2023 Aug 11, 2023	SELL	$0.43 - $0.65 $49,444 - $74,741	-114,987 Reduced 19.04%	488,961 $249,000
Q1 2023 May 16, 2023	BUY	$0.46 - $0.81 $53,291 - $93,839	115,851 Added 23.74%	603,948 $380,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $261.0 $395,972 - $207 Million	-791,945 Reduced 61.87%	488,097 $317,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $135,553 - $42 Million	130,340 Added 11.34%	1,280,042 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $322,342 - $974,890	786,202 Added 216.29%	1,149,702 $1.43 Million
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $271,097 - $511,587	-437,254 Reduced 54.61%	363,500 $237,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $228,263 - $395,796	-209,416 Reduced 20.73%	800,754 $873,000
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $216,233 - $409,942	150,162 Added 17.46%	1,010,170 $1.84 Million
Q2 2021 Aug 11, 2021	BUY	$2.63 - $3.67 $764,730 - $1.07 Million	290,772 Added 51.08%	860,008 $2.27 Million
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $1.5 Million - $2.99 Million	-533,669 Reduced 48.39%	569,236 $2.05 Million
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $109,691 - $162,175	-52,484 Reduced 4.54%	1,102,905 $2.78 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $429,057 - $615,760	179,522 Added 18.4%	1,155,389 $2.91 Million
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $257,686 - $434,552	-117,130 Reduced 10.72%	975,867 $3.2 Million
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $2.13 Million - $5.59 Million	-1,121,873 Reduced 50.65%	1,092,997 $2.68 Million
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $4.59 Million - $6.22 Million	1,163,200 Added 110.61%	2,214,870 $10.5 Million
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $13,277 - $22,312	3,215 Added 0.31%	1,051,670 $4.5 Million
Q2 2019 Aug 16, 2019	BUY	$3.98 - $6.2 $73,271 - $114,142	18,410 Added 1.79%	1,048,455 $6.11 Million
Q2 2019 Aug 14, 2019	SELL	$3.98 - $6.2 $726,162 - $1.13 Million	-182,453 Reduced 15.05%	1,030,045 $6.01 Million
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $153,952 - $338,694	-76,976 Reduced 5.97%	1,212,498 $4.67 Million
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $1.01 Million - $2.28 Million	629,233 Added 95.3%	1,289,474 $2.41 Million
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $272,187 - $393,828	-120,437 Reduced 15.43%	660,241 $2.11 Million
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $410,251 - $671,074	-135,845 Reduced 14.82%	780,678 $2.36 Million
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $2.53 Million - $3.76 Million	-732,467 Reduced 44.42%	916,523 $3.59 Million
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $14.1 Million - $23 Million	-3,515,170 Reduced 68.07%	1,648,990 $6.83 Million
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $25.8 Million - $33.9 Million	5,164,160	5,164,160 $31.7 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account